All > Massachusetts Investigators

Gregory Michaud, MD

Brigham and Women's Hospital

Boston, Massachusetts - 02115 (617-732-6237)

CLINICAL TRIALS 2
CONDITIONS3
INTERVENTIONS4
SINCE2009

Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation

October 2009 - December 2012

Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial

August 2009 - September 2015

Stroke

Atrial Fibrillation

Arrhythmias, Cardiac

Placebo

Ibutilide

Left Atrial Ablation

Rate Or Rhythm Control Therapy

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Gregory Michaud, MD

Brigham and Women's Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP